Bevacizumab and Bortezomib in Patients With Advanced Malignancy

Clinical trial NCT00428545 · COMPLETED

Trial details

NCT number: NCT00428545
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy Lymphoma Myeloma Solid Tumors

Start date: 2007-01-01
Primary completion: 2012-11-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.